hotspot -WSS

hotspot

author：comprehensive 2025-09-27 09:57:48 - browse：78

A yellow number 3 with an eye is surrounded by smaller, black number 3s on a pink background — 3 to watch coverage from STAT — Christine Kao/STAT

Health tech hopefuls might once have been used to a wealth of job options, especially in the pandemic’s early stages when investors pumped record-breaking dollar amounts into an unprecedented number of ventures.

That glut of opportunities meant workers could bargain harder for better job offers, demanding perks and flexibilities like permanent remote work or expensive fertility benefits. But belt-tightening and market consolidation across health tech companies have tipped the scales back in favor of employers, who are continuing to hire — for a seemingly dwindling number of positions.

It might feel like a downturn, although it’s possible that the industry is simply easing back into its pre-pandemic normal, before the massive infusion of venture dollars and the hype surrounding virtual care, said Brookings Institution research fellow Niam Yaraghi, who studies health care employment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Bernie Sanders bashes nonprofit hospitals over their tax breaks

WSS

He's a Nobel laureate. Critics say he was misleading on Covid

Alabama frozen embryo ruling has major implications for IVF clinics

Dario to buy mental health app maker Twill in cash and stock deal

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Akero's treatment for NASH falls short in cirrhosis study

Cancer cells are shown to suck energy source from immune cells

explore

hotspot

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

The Harvard botanist who searched for psychedelics in the Amazon

Jerome Adams on the need for new antivirals for Covid

How doctors and nurses shape Google's AI

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Hollywood unions extend contract negotiations for actors

STAT Readout: Today's biotech news includes Sana and Amylyx

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

hotspot

R1 RCM gets $5.8 billion buyout offer from private equity firm

R1 RCM gets $5.8 billion buyout offer from private equity firm

Peter Marks talks Operation Warp Speed for Rare Diseases

Obesity drugs seen as possible treatment for liver disease MASH

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Cancer cells are shown to suck energy source from immune cells

Wikipedia

leisure time

knowledge

explore